Business
Press Release Sep 14 2023
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 14, 2023, titled "Strides receives tentative USFDA approval for Dolutegravir tablets".
About this update from Strides Pharma Science Ltd
Strides Pharma Science Limited has informed the Exchange regarding a press release dated September 14, 2023, titled "Strides receives tentative USFDA approval for Dolutegravir tablets". View Attachment
View stock analysis, news, and events for Strides Pharma Science Ltd